Wesso and others, I think you'll find from now on, it won't be millions spent on vax - just thousands.
It's still a very worthwhile division of AHZ but with the new RNA collaboration, and some inexpensive initial trials elsewhere, it will just tick along on a skinny budget.
WP is all about getting this company profitable, and quickly. Don't sweat on the small stuff.
"Take a Closer Look", page-839
-
- There are more pages in this discussion • 389 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |